Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-17-002004

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chen Henry · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-05-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +10,000 $13.58 2027-05-17 10,000 10,000 D
2017-05-17 Grant or award : show line 2 in the form Stock Option (Right to Buy) +5,000 $13.58 2027-05-17 5,000 5,000 D
Loading xslF345X03/primarydocument.xml…